| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Revenue | $852.7M | +34.1% |
| Cost of Revenue | $287.0M | +30.9% |
| Gross Profit | $565.6M | +35.9% |
| R&D Expense | $102.9M | +34.2% |
| SG&A Expense | $163.7M | +36.7% |
| Operating Income | $84.6M | +45.7% |
| Pre-tax Income | $83.6M | +46.4% |
| Income Tax | -$7.2M | +47.6% |
| Net Income | $90.8M |
| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $139.8M | -30.9% |
| Accounts Receivable | $15.8M | +151.4% |
| Current Assets | $4.23B | +108.2% |
| Total Assets | $4.81B | +99.1% |
| Current Liabilities | $4.12B | +120.7% |
| Total Liabilities | $4.20B | +116.5% |
| Stockholders' Equity | $613.5M | +28.6% |
| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $155.1M | +24.2% |
| Capital Expenditures | $18.1M | +91.0% |
| Investing Cash Flow | -$479.8M | -1090.9% |
| Financing Cash Flow | $2.17B | +674.5% |
| Free Cash Flow | $137.0M | +18.7% |
| +28.2% |
| EPS (Basic) | $1.65 | +26.9% |
| EPS (Diluted) | $1.61 | +27.8% |